EKSO
Ekso Bionics Holdings Stock Analysis
AI Rating
- Quality0/10
- Growth↑ 6/10
- Momentum↑ 9/10
EKSO Growth
- Revenue Y/Y↓ -28.60%
- EPS Y/Y↑ 41.76%
- FCF Y/Y↓ -21.31%
EKSO Profitability
- Gross margin ↑ 53.50%
- EPS margin↓ -91.40%
- ROIC↓ -101.40%
EKSO Risk
- Debt / Equity↓ 0.5
- Debt / FCF↓ 0.3
- Interest coverage↓ -36.8
Ekso Bionics Holdings stock volatility is in-line with the overall market. We give it a Great risk rating.